![](/img/cover-not-exists.png)
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
Xin, Pengliang, Li, Chuntuan, Zheng, Yan, Peng, Qunyi, Xiao, Huifang, Huang, Yuanling, Zhu, XiongpengVolume:
Volume11
Language:
english
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S132092
Date:
April, 2017
File:
PDF, 4.37 MB
english, 2017